1. ScholarBank@NUS

Wei Peng Yong

rp05452

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wei Peng Yong
Variants
Yong, W.-P.
Yong, W.P.
Peng, Y.W.
 
Main Affiliation
 
Faculty
 
Email
csiywp@nus.edu.sg
 

Publications

Results 41-60 of 74 (Search time: 0.011 seconds).

Issue DateTitleAuthor(s)
412016Knockdown of POLA2 increases gemcitabine resistance in lung cancer cellsKoh, V; Kwan, H.Y; Tan, W.L; Mah, T.L; Yong, W.P 
4217-Oct-2012Methylation subtypes and large-scale epigenetic alterations in gastric cancerZouridis, H.; Deng, N. ; Ivanova, T.; Zhu, Y.; Wong, B.; Huang, D.; Wu, Y.H.; Wu, Y.; Tan, I.B.; Liem, N.; Gopalakrishnan, V.; Luo, Q.; Wu, J.; Lee, M.; Yong, W.P. ; Goh, L.K. ; Teh, B.T.; Rozen, S. ; Tan, P. 
432014Novel SNP improves differential survivability and mortality in non-small cell lung cancer patientsMah, T.L; Yap, X.N.A; Limviphuvadh, V; Li, N; Sridharan, S; Kuralmani, V; Feng, M ; Liem, N; Adhikari, S; Yong, W.P ; Soo, R.A ; Maurer-Stroh, S ; Eisenhaber, F ; Tong, J.C 
4421-Oct-2022Oncofetal protein IGF2BP1 regulates IQGAP3 expression to maintain stem cell potential in cancerMyint, Khine ; Chuang, Linda Shyue Huey ; Teh, Yu Xuan ; Mawan, Nur Astiana ; Shi, Edward Jizhong; Mok, Michelle Meng Huang ; Nuttonmanit, Napat ; Matsuo, Junichi ; Li, Ying ; Yang, Henry; Okabe, Atsushi; Kaneda, Atsushi; Osato, Motomi ; So, Jimmy Bok-Yan ; Yong, Wei Peng ; Tan, Patrick ; Yeoh, Khay Guan ; Ito, Yoshiaki 
528-Mar-2018Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signalingWang, Lingzhi ; Syn, Nicholas Li-Xun; Subhash, Vinod Vijay; Any, Yijia; Thuya, Win Lwin ; Cheow, Esther Sok Hwee ; Kong, Li Ren ; Yu, Fenggang ; Peethala, Praveen C. ; Wong, Andrea Li-Ann ; Laljibhai, Hirpara J. ; Chinnathambi, Arunachalam; Ong, Pei Shi ; Ho, Paul Chi-Lui ; Sethi, Gautam ; Yong, Wei Peng ; Goh, Boon Cher 
6Jul-2011Pharmacodynamic evaluation of the target efficacy of SB939, an oral HDAC inhibitor with selectivity for tumor tissueNovotny-Diermayr, V.; Sausgruber, N.; Loh, Y.K.; Pasha, M.K.; Jayaraman, R.; Hentze, H.; Yong, W.-P. ; Goh, B.-C.; Toh, H.-C.; Ethirajulu, K.; Zhu, J.; Wood, J.M.
72016Pharmacogenetics-Guided Phase i Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid TumoursSoo, R.A ; Syn, N; Lee, S.-C; Wang, L; Lim, X.-Y; Loh, M; Tan, S.-H ; Zee, Y.-K; Wong, A.L.-A ; Chuah, B; Chan, D; Lim, S.-E; Goh, B.-C ; Soong, R ; Yong, W.-P 
815-Jan-2013Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinomaToh, H.C.; Chen, P.-J.; Carr, B.I.; Knox, J.J.; Gill, S.; Ansell, P.; McKeegan, E.M.; Dowell, B.; Pedersen, M.; Qin, Q.; Qian, J.; Scappaticci, F.A.; Ricker, J.L.; Carlson, D.M.; Yong, W.P. 
9Nov-2011Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignanciesYong, W.P. ; Goh, B.C.; Soo, R.A. ; Toh, H.C.; Ethirajulu, K.; Wood, J.; Novotny-Diermayr, V.; Lee, S.C. ; Yeo, W.L. ; Chan, D.; Lim, D.; Seah, E.; Lim, R.; Zhu, J.
1023-Feb-2022Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin +/- Trastuzumab in Advanced Solid TumorsLee, Matilda Xinwei; Wong, Andrea LA ; Ow, Samuel; Sundar, Raghav ; Tan, David SP ; Soo, Ross A ; Chee, Cheng Ean ; Lim, Joline SJ ; Yong, Wei Peng ; Lim, Siew Eng; Goh, Boon Cher ; Wang, Lingzhi ; Lee, Soo Chin 
111-Jun-2022Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast CancerLim, JSJ ; Wong, ALA ; Ow, SGW ; Ngoi, NYL ; Chan, GHJ; Ang, YLE; Chong, WQ; Lim, SE ; Lim, YW; Lee, M; Choo, JRE; Tan, HL; Yong, WP ; Soo, RA ; Tan, DSP ; Chee, CE ; Sundar, R ; Yadav, K ; Jain, S ; Wang, L ; Tai, BC ; Goh, BC ; Lee, SC 
122012Potential therapeutic significance of HER-family in esophageal squamous cell carcinomaKono, K.; Mimura, K.; Fujii, H.; Shabbir, A.; Yong, W.-P. ; So, J.
13Aug-2012Prevalence of the Coprescription of Clinically Important Interacting Drug Combinations Involving Oral Anticancer Agents in Singapore: A Retrospective Database StudyKo, Y. ; Tan, S.L.D.; Chan, A. ; Wong, Y.-P.; Yong, W.-P. ; Ng, R.C.H.; Lim, S.-W. ; Salim, A. 
142019PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoproteinThura M.; Al-Aidaroos A.Q.; Gupta A. ; Chee C.E. ; Lee S.C. ; Hui K.M. ; Li J.; Guan Y.K. ; Yong W.P. ; So J. ; Chng W.J. ; Ng C.H. ; Zhou J. ; Wang L.Z. ; Yuen J.S.P. ; Ho H.S.S. ; Yi S.M.; Chiong E. ; Choo S.P. ; Ngeow J. ; Ng M.C.H. ; Chua C. ; Yeo E.S.A. ; Tan I.B.H. ; Sng J.X.E.; Tan N.Y.Z.; Thiery J.P. ; Goh B.C. ; Zeng Q. 
152-Nov-2021PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019)Thura, Min; Al-Aidaroos, Abdul Qader; Gupta, Abhishek ; Chee, Cheng Ean ; Lee, Soo Chin ; Hui, Kam Man ; Li, Jie; Guan, Yeoh Khay ; Yong, Wei Peng ; So, Jimmy; Chng, Wee Joo ; Ng, Chin Hin ; Zhou, Jianbiao ; Wang, Ling Zhi; Yuen, John Shyi Peng; Ho, Henry Sun Sien ; Yi, Sim Mei; Chiong, Edmund ; Choo, Su Pin ; Ngeow, Joanne; Ng, Matthew Chau Hsien ; Chua, Clarinda; Yeo, Eugene Shen Ann ; Tan, Iain Bee Huat ; Sng, Joel Xuan En; Tan, Nicholas Yan Zhi; Thiery, Jean Paul ; Goh, Boon Cher ; Zeng, Qi 
162012Prognostic value of different CT measurements in early therapy response evaluation in patients with metastatic colorectal cancerHuellner, M.W.; Hennedige, T.P.; Winterhalder, R.; Zander, T.; Venkatesh, S.K.; Yong, W.P. ; Soo, R.A. ; Seifert, B.; Treumann, T.C.; Strobel, K.; Veit-Haibach, P.
172009Rapid determination of gemcitabine and its metabolite in human plasma by LC-MSMS through micro protein precipitation with minimum matrix effectWang, L.-Z. ; Yong, W.-P. ; Soo, R.-A. ; Lee, S.-C. ; Soong, R. ; Lee, H.-S.; Goh, B.-C.
181-Oct-2011Recent progress and clinical importance on pharmacogenetics in cancer therapySoh, T.I.P.; Yong, W.P. ; Innocenti, F.
191-May-2018Resisting resistance to cancer immunotherapyRAGHAV SUNDAR; Lam, W.S.-T.; Wang, L.Z.; Roudi, R.; Yong, W.-P. ; Syn, N.L.
2023-Aug-2011Sequential expression of putative stem cell markers in gastric carcinogenesisWang, T. ; Ong, C.W. ; Shi, J. ; Srivastava, S. ; Yan, B.; Cheng, C.L.; Yong, W.P. ; Chan, S.L.; Yeoh, K.G.; Iacopetta, B.; Salto-Tellez, M.